Italia markets closed

ABIO Jul 2024 2.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,95000,0000 (0,00%)
Alla chiusura: 03:32PM EDT
Schermo intero
Chiusura precedente0,9500
Aperto0,9500
Denaro0,0000
Domanda1,6500
Prezzo d'esercizio2,50
Scadenza2024-07-19
Min-Max giorno0,9500 - 0,9500
Contratto - Min-MaxN/D
Volume2
Open Interest2
  • GlobeNewswire

    ARCA biopharma Announces Second Quarter 2023 Financial Results

    Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., July 21, 2023 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported second quarter 2023 financial results and provided a corporate update. In April 2022, the Board of Di